¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2020 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2020-08-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2020 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2020-08-21
±³À°ÀÏÀÚ : 2020-08-21
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À° (½Ç½Ã°£)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2020 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ(18.7 ¸íĪº¯°æ ´ëÇÑÈ­Çпä¹ýÇÐȸ)
´ã´çÀÚ : ¹Ú½ÂÀ±
¿¬¶ôó : 02-557-1755  
À̸ÞÀÏ : ksc@ksac.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í È¸¿ø Àü¹®ÀÇ 10¸¸¿ø, ÀüÀÓÀÇ 8¸¸¿ø, Àü°øÀÇ 5¸¸¿ø ºñȸ¿ø Àü¹®ÀÇ 12¸¸¿ø, ÀüÀÓÀÇ 10¸¸¿ø, Àü°øÀÇ 7¸¸¿ø ÀÏ¹Ý 12¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 08:50~09:30 BIKTARVY with Korean patients: a strategy to improve patients¡¯ adherence  Áø¹ü½Ä(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 09:30~10:05 Epidemiology of COVID-19 in Korea  Ãµº´Ã¶(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 10:05~10:40 Infection prevention and control in community and hospitals in Korea  ÀÌÀç°©(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 10:40~11:15 Laboratory response to COVID-19 pandemic and future perspectives  ÀÌÇõ¹Î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 11:15~11:55 Clinical features and management of COVID-19 in adult patients  ±è³²Áß(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 11:55~12:30 Clinical features and management of COVID-19 in pediatric patients  ÃÖÀºÈ­(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 12:30~13:10 Therapeutic role of ¥â-lactam/¥â-lactamase inhibitors to gram-negative nosocomial pneumonia, with special emphasis on ceftolozane/tazobactam  °­Ã¶ÀÎ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 13:10~13:50 New consideration for PLHIV ; metabolic syndrome & Long term toxicity  ±è¿¬¼÷(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 14:00~14:30 Recent ethical topics in biomedical articles  È«¼ºÅÂ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 16:00~16:30 Pediatric use of fluoroquinolone and doxycycline  ¹Ú¼öÀº(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 16:30~17:00 IV vs. oral therapy for severe infectious diseases  ¹Ú±âÈ£(°æÈñÀÇ´ë) 
±³À°½Ã°£ 08¿ù 21ÀÏ ½ºÆ©µð¿À 17:00~17:40 Carbapenem-sparing therapy in the era of multidrug resistance  °­Ã¶ÀÎ(¼º±Õ°üÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2020 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2020-08-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÁ¾¾ç³»°úÇÐȸ (¿Â¶óÀÎ) Best of ASCO 2020 in Korea : 2020-08-21
´ÙÀ½±Û (¿Â¶óÀÎ) 2020³â ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ*´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2020-08-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 37 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 35 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 31 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 26 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 31 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 46 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 25 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 23 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 22 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 20 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 27 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 28 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷